Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Will Eli Lilly’s Rezvoglar Be Able To Compete With Interchangeable Semglee?
FDA Approves Second Insulin Glargine Biosimilar Rival To Lantus
Dec 23 2021
•
By
Dave Wallace
How will non-interchangeable Rezvoglar fare against Semglee? • Source: Brain light / Alamy Stock Photo
More from Biosimilars
More from Products